Clonidine in Children
Links shared publicly online about this topic
Pediatrics Article | Clonidine
mdlinx.com — “Oral bioavailability of clonidine in children” View full resource at mdlinx.com
Most Recently Shared on November 3, 2010 at 2:13 pm By:
Oral bioavailability of clonidine in children: Paediatric Anaesthesia http://bit.ly/a1QpXP #peds
Shionogi Announces FDA Approval of Kapvay - The First and Only Therapy Approved for Use with Stimulant Medication for the Treatment of ADHD
drugs.com — “Kapvay (clonidine hydrochloride) is used to treat Attention Deficit Hyperactivity Disorder (ADHD). Includes Kapvay side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on October 4, 2010 at 11:57 pm By:
FDA Approves Kapvay for the Treatment of ADHD - http://bit.ly/9mCUK6
First ADHD Add-On Drug Approved | Psych Central News
psychcentral.com — “The U.S. Food and Drug Administration (FDA) has given the green light to the nonstimulant medication Kapvay (clonidine hydrochloride) as the first drug used to” View full resource at psychcentral.com
Most Recently Shared on October 7, 2010 at 2:36 pm By:
Shionogi Announces FDA Approval Of KAPVAY™ - The First And Only Therapy Approved For Use With Stimulant Medication For The Treatment Of ADHD
medicalnewstoday.com — “Shionogi Inc., the U.S.-based group company of Shionogi & Co., Ltd., announced the U.S. Food and Drug Administration approval of the non-stimulant medication KAPVAY™ (clonidine hydrochloride” View full resource at medicalnewstoday.com
Most Recently Shared on October 6, 2010 at 3:05 pm By:
Shionogi Announces FDA Approval Of KAPVAY™ - The First And Only Therapy Approved For Use With Stimulant Medicati... http://mnt.to/3KPx
Neurology Article | Attention Deficit Disorder with Hyperactivity
mdlinx.com — “Clonidine Extended-Release Tablets as Add-on Therapy to Psychostimulants in Children and Adolescents With ADHD” View full resource at mdlinx.com
Most Recently Shared on June 8, 2011 at 11:56 am By:
Clonidine Extended-Release Tablets as Add-on Therapy to Psychostimulants in Children and Adolescents With... http://bit.ly/me919S #neuro
Kapvay approved for ADHD - MPR
empr.com — “The FDA has approved Kapvay (clonidine HCl extended-release tablets, from Shionogi) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents ages 6"17 years old.” View full resource at empr.com
Most Recently Shared on October 4, 2010 at 3:00 pm By:
MPR News: Kapvay approved for ADHD: The FDA has approved Kapvay (clonidine HCl extended-release tablets, from Shio... http://bit.ly/9MiFxk
Kapvay available for ADHD - ONA
oncologynurseadvisor.com — “Shionogi announced the availability of Kapvay (clonidine HCl extended-release tablets) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents ages 6--17 years old.” View full resource at oncologynurseadvisor.com
Most Recently Shared on January 10, 2011 at 4:17 pm By:
Drug Combo May Help Treat Kids With ADHD
m.webmd.com — “Combining an extended-release version of the blood pressure pill clonidine with a stimulant may benefit children with attention deficit hyperactivity disorder (ADHD) who are not getting adequate relief from stimulants alone, according to a new study.” View full resource at m.webmd.com
Most Recently Shared on May 12, 2011 at 6:43 pm By:
Drug Combo May Help Treat Kids With ADHD: Combining an extended-release version of the blood pressure pill... http://bit.ly/mvZYav #adhd
Phase 3 Study of Kapvay for ADHD - MPR
empr.com — “Shionogi Inc. announced thatdata from its Phase 3 study of Kapvay (clonidine hydrochloride) extended-release tablets combined with stimulant medications for the treatment of attention deficit hyperactivity disorder in children and adolescents 6-17 years of age.” View full resource at empr.com
Most Recently Shared on May 9, 2011 at 3:18 pm By:
MPR News: Phase 3 Study of Kapvay for ADHD: Shionogi Inc. announced that data from its Phase 3 study of Kapvay (... http://bit.ly/jBLDDp
Phase 3 Study of Kapvay for ADHD - ONA
oncologynurseadvisor.com — “Shionogi Inc. announced thatdata from its Phase 3 study of Kapvay (clonidine hydrochloride) extended-release tablets combined with stimulant medications for the treatment of attention deficit hyperactivity disorder in children and adolescents 6-17 years of age.” View full resource at oncologynurseadvisor.com
Most Recently Shared on May 9, 2011 at 2:43 pm By:
Shionogi brings KAPVAY ADHD drug to the U.S market
news-medical.net — “Shionogi Inc., the U.S.-based group company of Shionogi & Co., Ltd., today announced a true milestone as it marks the first commercial availability for the non-central nervous system stimulant medication KAPVAY™, an extended-release oral formulation of clonidine for Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents.” View full resource at news-medical.net
Most Recently Shared on January 10, 2011 at 7:50 pm By:
Pregnancy News: Shionogi brings KAPVAY ADHD drug to the U.S market: Shionogi Inc., the U.S.-based group company ... http://bit.ly/hPgK0h
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
-
Peter H Brown
Peter H Brown Clinical Psychologist. I'm also a Husband & Dad & wannabe techno-junkie
Advertisement

